BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16285995)

  • 1. 3'UTR/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects.
    Puccetti L; Pasqui AL; Pastorelli M; Ciani F; Palazzuoli A; Gioffrè W; Auteri A; Bruni F
    Atherosclerosis; 2005 Dec; 183(2):322-8. PubMed ID: 16285995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
    Puccetti L; Sawamura T; Pasqui AL; Pastorelli M; Auteri A; Bruni F
    Eur J Clin Invest; 2005 Jan; 35(1):47-51. PubMed ID: 15638819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia.
    Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Ciani F; Palazzuoli A; Acampa M; Auteri A
    Eur J Clin Invest; 2008 Jan; 38(1):11-6. PubMed ID: 18173546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment.
    Puccetti L; Pasqui AL; Bruni F; Pastorelli M; Ciani F; Palazzuoli A; Pontani A; Ghezzi A; Auteri A
    Int J Cardiol; 2007 Jun; 119(1):41-7. PubMed ID: 17050011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects.
    Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Sawamura T; Gioffre WR; Auteri A; Puccetti L
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):417-28. PubMed ID: 16244767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.
    Puccetti L; Santilli F; Pasqui AL; Lattanzio S; Liani R; Ciani F; Ferrante E; Ciabattoni G; Scarpini F; Ghezzi A; Auteri A; Davì G
    Atherosclerosis; 2011 Jan; 214(1):122-8. PubMed ID: 21056418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent effect of statins on platelet function in hypercholesterolaemia.
    Puccetti L; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Angori P; Auteri A; Bruni F
    Eur J Clin Invest; 2002 Dec; 32(12):901-8. PubMed ID: 12534449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients.
    Chan LW; Luo XP; Ni HC; Shi HM; Liu L; Wen ZC; Gu XY; Qiao J; Li J
    Braz J Med Biol Res; 2015 Feb; 48(2):167-73. PubMed ID: 25466164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
    Cerda A; Genvigir FD; Arazi SS; Hirata MH; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
    Clin Chim Acta; 2010 May; 411(9-10):631-7. PubMed ID: 20064494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet hyperactivity after statin treatment discontinuation.
    Puccetti L; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Leo A; Cercignani M; Palazzuoli A; Auteri A; Bruni F
    Thromb Haemost; 2003 Sep; 90(3):476-82. PubMed ID: 12958617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.
    Oka H; Ikeda S; Koga S; Miyahara Y; Kohno S
    Heart Vessels; 2008 Jul; 23(4):249-56. PubMed ID: 18649055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptor.
    Chu CS; Wang YC; Lu LS; Walton B; Yilmaz HR; Huang RY; Sawamura T; Dixon RA; Lai WT; Chen CH; Lu J
    PLoS One; 2013; 8(8):e70533. PubMed ID: 23950953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry.
    Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J
    Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
    Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased superoxide anion production by platelets in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Caccese D; Pulcinelli FM; Lenti L; Magnaterra R; Martini F; Lauro R; Violi F
    Thromb Haemost; 2002 May; 87(5):796-801. PubMed ID: 12038779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus.
    Aydemir B; Baykara O; Cinemre FB; Cinemre H; Tuten A; Kiziler AR; Akdemir N; Oncul M; Kaya B; Sozer V; Erkorkmaz U; Uzun H
    Arch Gynecol Obstet; 2016 Mar; 293(3):517-27. PubMed ID: 26296941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects.
    Bruni F; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Cercigani M; Leo A; Auteri A; Puccetti L
    Int J Cardiol; 2004 Jun; 95(2-3):269-74. PubMed ID: 15193831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.
    Olsson AG; Istad H; Luurila O; Ose L; Stender S; Tuomilehto J; Wiklund O; Southworth H; Pears J; Wilpshaar JW;
    Am Heart J; 2002 Dec; 144(6):1044-51. PubMed ID: 12486429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.